Antonino Neri

UNVERIFIED PROFILE

Are you Antonino Neri?   Register this Author

Register author

Antonino Neri

Publications by authors named "Antonino Neri"

Are you Antonino Neri?   Register this Author

100Publications

-Reads

A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma.

Sci Rep 2018 Apr 26;8(1):6557. Epub 2018 Apr 26.

Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.

View Article
April 2018

Long Non-Coding RNAs in Multiple Myeloma.

Genes (Basel) 2018 Feb 1;9(2). Epub 2018 Feb 1.

Department of Oncology and Hemato-Oncology, University of Milan, and Hematology, Fondazione Ca' Granda IRCCS Policlinico, 20122 Milan, Italy.

View Article
February 2018

Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.

Oncotarget 2018 Feb 23;9(15):12534. Epub 2018 Feb 23.

Department of Experimental Oncology and Molecular Medicine, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article
February 2018

Targeting Notch as a Therapeutic Approach for Human Malignancies.

Curr Pharm Des 2017 ;23(1):108-134

Department of Health Sciences, Universita degli Studi di Milano, via A. Di Rudini 8, I-20142, Milano, Italy.

View Article
January 2018

Biological and molecular characterization of a rare case of cutaneous Richter syndrome.

Hematol Oncol 2017 Dec 12;35(4):869-874. Epub 2016 Jul 12.

OncoHematology Unit, Fondazione Ca' Granda IRCCS, Ospedale Maggiore Policlinico, Milan, Italy.

View Article
December 2017

Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells.

Cancer Lett 2017 12 23;410:201-211. Epub 2017 Sep 23.

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. Electronic address:

View Article
December 2017

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma.

Oncotarget 2017 Dec 20;8(63):106527-106537. Epub 2017 Nov 20.

Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.

View Article
December 2017

Long non-coding RNAs in B-cell malignancies: a comprehensive overview.

Oncotarget 2017 Sep 20;8(36):60605-60623. Epub 2017 Apr 20.

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Hematology, Fondazione Cà Granda IRCCS Policlinico, Milano, Italy.

View Article
September 2017

Utilizing next-generation sequencing in the management of multiple myeloma.

Expert Rev Mol Diagn 2017 07 26;17(7):653-663. Epub 2017 May 26.

a Department of Oncology and Hemato-oncology , Università degli Studi di Milano , Milano , Italy.

View Article
July 2017

Primary Soft Tissue Lymphomas: Description of Seven Cases and Review of the Literature.

Pathol Oncol Res 2017 Apr 1;23(2):281-286. Epub 2016 Aug 1.

Division of Pathology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, via F. Sforza, 35, 20122, Milan, Italy.

View Article
April 2017

Primary plasma cell leukemia 2.0: advances in biology and clinical management.

Expert Rev Hematol 2016 Nov 24;9(11):1063-1073. Epub 2016 Oct 24.

e Scientific Direction , IRCCS-CROB, Referral Cancer Center of Basilicata , Rionero in Vulture , Italy.

View Article
November 2016

In Silico Characterization of miRNA and Long Non-Coding RNA Interplay in Multiple Myeloma.

Genes (Basel) 2016 Nov 29;7(12). Epub 2016 Nov 29.

Department of Oncology and Hemato-Oncology, University of Milano, 20122 Milan, Italy.

View Article
November 2016

Compendium of FAM46C gene mutations in plasma cell dyscrasias.

Br J Haematol 2016 08 12;174(4):642-5. Epub 2015 Oct 12.

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

View Article
August 2016

Long non-coding RNAs in normal and malignant hematopoiesis.

Oncotarget 2016 Aug;7(31):50666-50681

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy.

View Article
August 2016

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.

Mol Cancer Ther 2016 06 18;15(6):1364-75. Epub 2016 May 18.

Department of Experimental and Clinical Medicine, Magna Graecia University and Translational Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

View Article
June 2016

Primary Plasma Cell Leukemia: Identity Card 2016.

Curr Treat Options Oncol 2016 Apr;17(4):19

Department of Oncology and Hemato-oncology, University of Milano, Hematology, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.

View Article
April 2016

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.

Oncotarget 2016 Mar;7(11):12731-47

Department of Experimental Oncology and Molecular Medicine, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article
March 2016

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.

Blood 2016 Jan 13;127(2):221-32. Epub 2015 Oct 13.

Department of Molecular Biotechnology and Health Sciences, Center for Experimental Research and Medical Studies, University of Turin, Turin, Italy; Department of Pathology, New York University Cancer Center, New York University School of Medicine, New York, NY.

View Article
January 2016

Notch signaling deregulation in multiple myeloma: A rational molecular target.

Oncotarget 2015 Sep;6(29):26826-40

Department of Health Sciences, Università degli Studi di Milano, 20142 Milano, Italy.

View Article
September 2015

PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation.

Genes Chromosomes Cancer 2015 Aug 6;54(8):516-526. Epub 2015 Jun 6.

Department of Health Science, Università Degli Studi Di Milano, via A. Di Rudinì 8, 20142, Milan, Italy.

View Article
August 2015

The ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNA.

Nucleic Acids Res 2015 May 29;43(10):5182-93. Epub 2015 Apr 29.

Functional Genomics of Cancer Unit, Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, 20133 Milan, Italy Università Vita-Salute San Raffaele, Milan, 20132, Italy

View Article
May 2015

Long term assessment of intralipotherapy in Madelung's disease.

Indian J Plast Surg 2014 Sep-Dec;47(3):427-31

Advanced Technologies for Regenerative Medicine and Inductive Surgery Research Centre, University of Pavia, Viale Brambilla 74, Italy ; Department of Clinical Surgical Diagnostic and Pediatric Sciences, Plastic and Reconstructive Surgery, University of Pavia, Via Aselli 45, Italy ; Plastic and Reconstructive Surgery Unit, Salvatore Maugeri Research and Care Institute, Via Salvatore Maugeri 10, Italy.

View Article
January 2015

A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.

J Cell Physiol 2014 Dec;229(12):2106-16

Department of Experimental and Clinical Medicine, Magna Graecia University, Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.

View Article
December 2014

Autoimmune cytopenias in chronic lymphocytic leukemia.

Am J Hematol 2014 Nov 7;89(11):1055-62. Epub 2014 Jul 7.

Department of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza.

View Article
November 2014

Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.

Genes Chromosomes Cancer 2014 Jul 4;53(7):612-21. Epub 2014 Apr 4.

Department of Clinical Sciences and Community Health, Center of Molecular and Genetic Epidemiology, University of Milan, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

View Article
July 2014

Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.

Nat Med 2014 Jun 11;20(6):599-606. Epub 2014 May 11.

1] Functional Genomics of Cancer Unit, Division of Molecular Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy. [2] Università Vita-Salute San Raffaele, Milan, Italy. [3] MAGIC (Microenvironment and Genes in Cancers of the blood) Interdivisional Research Program, IRCCS San Raffaele Scientific Institute, Milan, Italy. [4].

View Article
June 2014

Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.

Oncotarget 2014 May;5(10):3039-54

Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.

View Article
May 2014

Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line.

Genes Chromosomes Cancer 2014 Feb 5;53(2):154-67. Epub 2013 Nov 5.

Department of Clinical Sciences and Community Health, University of Milano and Hematology-CTMO, Fondazione Cà Granda, IRCCS Policlinico, Milano, Italy.

View Article
February 2014

miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.

Cell Cycle 2013 Dec 25;12(23):3650-62. Epub 2013 Sep 25.

Department of Experimental and Clinical Medicine; Magna Graecia University and Medical Oncology Unit; T. Campanella Cancer Center; Salvatore Venuta University Campus; Catanzaro, Italy.

View Article
December 2013

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

Clin Cancer Res 2013 Nov 13;19(21):5890-900. Epub 2013 Sep 13.

Authors' Affiliations: Department of Onco-Hematology, A.O. of Cosenza, Cosenza; Department of Clinical Sciences and Community Health, University of Milano and Hematology 1 CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano; SS Molecular Diagnostics, Scientific Direction, and Direzione Scientifica, IRCCS, San Martino IST, Genoa; Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara; Division of Hematology, A.O. Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia; Division of Hematology, University of Messina, Messina; Department of Oncology and Hematology, Pugliese-Ciaccio Hospital; University of Magna Graecia and Cancer Center, Catanzaro; Division of Hematology, Department of Biomedical Sciences, University of Catania and Ferrarotto Hospital, Catania; and Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.

View Article
November 2013

Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL).

Leuk Res 2013 Jul 22;37(7):809-15. Epub 2013 Apr 22.

Fondazione Matarelli, Dipartimento di Farmacologia Chemioterapia e Tossicologia Medica, Università degli Studi di Milano, Milano, Italy.

View Article
July 2013

Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing.

Expert Opin Biol Ther 2013 Jun 24;13 Suppl 1:S55-68. Epub 2013 Apr 24.

University of Milan, Department of Clinical Sciences and Community Health, F. Sforza, 35 - 20122 Milan, Italy.

View Article
June 2013

Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.

Expert Opin Biol Ther 2013 Jun 22;13 Suppl 1:S125-37. Epub 2013 May 22.

Magna Graecia University and T. Campanella Cancer Center, Department of Experimental and Clinical Medicine, Medical Oncology Unit, Viale Europa, 88100 Catanzaro, Italy.

View Article
June 2013

EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.

J Cell Physiol 2013 Apr;228(4):871-8

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

View Article
April 2013

Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.

Clin Cancer Res 2013 Apr 27;19(8):2096-106. Epub 2013 Feb 27.

Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University and T. Campanella Cancer Center, Catanzaro, Italy.

View Article
April 2013

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

Clin Cancer Res 2012 Nov 3;18(22):6260-70. Epub 2012 Oct 3.

Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T Campanella Cancer Center, Salvatore Venuta University Campus; Pathology Unit, Magna Graecia University, Catanzaro, Italy.

View Article
November 2012

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.

Oncotarget 2012 Oct;3(10):1246-58

Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.

View Article
October 2012

MicroRNAs in the pathobiology of multiple myeloma.

Curr Cancer Drug Targets 2012 Sep;12(7):823-37

Department of Clinical Sciences and Community Health, University of Milan, Hematology 1-CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

View Article
September 2012

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma.

Blood 2012 Aug 27;120(6):1274-81. Epub 2012 Jun 27.

Department of Clinical Sciences and Community Health, University of Milano, Hematology 1, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

View Article
August 2012